Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bosboom, W. M. J.
Right arrow Articles by Wokke, J. H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bosboom, W. M. J.
Right arrow Articles by Wokke, J. H. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 124, No. 12, 2427-2438, December 2001
© 2001 Oxford University Press

Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy

W. M. J. Bosboom1, L. H. van den Berg1, H. Franssen2, P. C. L. M. Giesbergen1, H. Z. Flach1, A. M. van Putten1, H. Veldman1 and J. H. J. Wokke1

1 Departments of Neurology and 2 Clinical Neurophysiology of the Rudolf Magnus Institute for Neurosciences, University Medical Center Utrecht, The Netherlands

Correspondence to: Leonard H. van den Berg, MD, Department of Neurology, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands E-mail: l.h.vandenberg{at}neuro.azu.nl

The objective of the study was to determine the diagnostic value of features of demyelination and inflammation in sural nerve biopsy specimens of patients with chronic inflammatory demyelinating polyneuropathy (CIDP). The features of (i) demyelination, (ii) axonal de- and regeneration and (iii) inflammation were investigated by measuring the number of onion bulbs, g ratio (axon diameter/total nerve fibre diameter), myelinated nerve fibre density, number of clusters and endoneurial area in 21 patients with CIDP, as well as in 13 patients with chronic idiopathic axonal polyneuropathy (CIAP) and six autopsy controls. In addition, teased fibres were classified and lengths of internodes measured. We found no difference in demyelinating features between patients with CIDP and CIAP, as the percentage of fibres with segmental de- and remyelination and the number of onion bulbs were similar in both polyneuropathy groups. The g ratio, expected to be higher in a demyelinating disease due to thinner myelin sheaths, was significantly lower in CIDP than CIAP. Evidence for axonal degeneration was found in both CIDP and CIAP, as both showed a decrease in myelinated nerve fibre density. There was no evidence of endoneurial oedema in CIDP, as the endoneurial area did not differ between CIDP, CIAP and the autopsy controls. Although significant differences of features of demyelination, axonal degeneration and inflammation were found in sural nerve biopsy specimens, there was a considerable overlap between abnormalities in CIDP and CIAP patients. In the majority of patients, quantitative analysis of light microscopical abnormalities in sural nerves was similar in CIDP and CIAP. Therefore, a sural nerve biopsy is of limited diagnostic value in CIDP.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
J. D. England, G. S. Gronseth, G. Franklin, G. T. Carter, L. J. Kinsella, J. A. Cohen, A. K. Asbury, K. Szigeti, J. R. Lupski, N. Latov, et al.
Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review): Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation
Neurology, January 13, 2009; 72(2): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
The French CIDP Study Group
Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy
Postgrad. Med. J., July 1, 2008; 84(993): 378 - 381.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
The French CIDP Study Group
Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy
J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 115 - 118.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
X. J. Caro, E. F. Winter, and A. J. Dumas
A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg
Rheumatology, February 1, 2008; 47(2): 208 - 211.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Sommer, S. Koch, M. Lammens, A. Gabreels-Festen, G. Stoll, and K. V. Toyka
Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP
Neurology, December 27, 2005; 65(12): 1924 - 1929.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. T. H. Van Asseldonk, L. H. Van den Berg, S. Kalmijn, J. H. J. Wokke, and H. Franssen
Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37{degrees}C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy
Brain, April 1, 2005; 128(4): 880 - 891.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. Koller, B. C. Kieseier, S. Jander, and H.-P. Hartung
Chronic Inflammatory Demyelinating Polyneuropathy
N. Engl. J. Med., March 31, 2005; 352(13): 1343 - 1356.
[Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Okuda, Y. Higashi, K. Kokame, C. Tanaka, H. Kondoh, and T. Miyata
Ndrg1-Deficient Mice Exhibit a Progressive Demyelinating Disorder of Peripheral Nerves
Mol. Cell. Biol., May 1, 2004; 24(9): 3949 - 3956.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. V. Toyka and R. Gold
The pathogenesis of CIDP: Rationale for treatment with immunomodulatory agents
Neurology, April 22, 2003; 60(90083): S2 - 7.
[Abstract] [Full Text]


Home page
NeurologyHome page
H. W. Sander and N. Latov
Research criteria for defining patients with CIDP
Neurology, April 22, 2003; 60(90083): S8 - 15.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.